Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
AVAILABLE
NCT04776694
Compassionate Use or Expanded Access of Dupilumab
Sponsor: Regeneron Pharmaceuticals
View on ClinicalTrials.gov
Summary
Provide Compassionate Use or Expanded Access of Dupilumab
Official title: Unapproved Dupilumab Indications for Potential Compassionate Use or Expanded Access
Key Details
Gender
All
Age Range
6 Months - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-09-01
Healthy Volunteers
Not specified
Conditions
Interventions
DRUG
Dupilumab
To be provided by Regeneron